HOME ›  業績一覧 ›  2020年業績

業績一覧

2020年業績

欧文原著 - 当研究室の2020年の業績です。

 

    1. Repetitive instructions at short intervals contribute to the improvement of inhalation technique.

      Baba R, Nakachi I, Masaki K, Amagai T, Ohno R, Takaoka H, Kamo T, Arai D, Takahashi H, Shinoda H, Fukunaga K.

      Asia Pac Allergy. 2020 Apr 27;10(2):e19. doi: 10.5415/apallergy.2020.10.e19. eCollection 2020 Apr.


    2. Exposure to Cigarette Smoke Enhances the Stemness of Alveolar Type 2 Cells.

      Tsutsumi A, Ozaki M, Chubachi S, Irie H, Sato M, Kameyama N, Sasaki M, Ishii M, Hegab AE, Betsuyaku T, Fukunaga K.

      Am J Respir Cell Mol Biol. 2020 Apr 27. doi: 10.1165/rcmb.2019-0188OC. Online ahead of print.


    3. Anti-TSLP antibodies: Targeting a master regulator of type 2 immune responses.

      Nakajima S, Kabata H, Kabashima K, Asano K.

      Allergol Int. 2020 Apr;69(2):197-203. doi: 10.1016/j.alit.2020.01.001. Epub 2020 Jan 21.


    4. A randomized controlled trial of a smoking cessation smartphone application with a carbon monoxide checker.

      Masaki K, Tateno H, Nomura A, Muto T, Suzuki S, Satake K, Hida E, Fukunaga K.

      NPJ Digit Med. 2020 Mar 12;3:35. doi: 10.1038/s41746-020-0243-5. eCollection 2020.


    5. Characteristics of Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension Assessed by Echocardiography in a Three-Year Observational Cohort Study.

      Nakayama S, Chubachi S, Sakurai K, Irie H, Tsutsumi A, Hashiguchi M, Itabashi Y, Murata M, Nakamura H, Asano K, Fukunaga K.

      Int J Chron Obstruct Pulmon Dis. 2020 Mar 3;15:487-499. doi: 10.2147/COPD.S230952. eCollection 2020.


    6. Successful Treatment for Hypercalcemia due to Cosecretion of Parathyroid Hormone-Related Protein and 1,25-Dihydroxyvitamin D3 in Non-Small-Cell Lung Cancer: A Case Report and Literature Review.

      Ogawa T, Miyata J, Fukunaga K, Kawana A, Inoue T.

      Case Rep Pulmonol. 2020 Jan 3;2020:2475725. doi: 10.1155/2020/2475725. eCollection 2020.


    7. IGF2 Autocrine-Mediated IGF1R Activation Is a Clinically Relevant Mechanism of Osimertinib Resistance in Lung Cancer.

      Manabe T, Yasuda H, Terai H, Kagiwada H, Hamamoto J, Ebisudani T, Kobayashi K, Masuzawa K, Ikemura S, Kawada I, Hayashi Y, Fukui K, Horimoto K, Fukunaga K, Soejima K.

      Mol Cancer Res. 2020 Apr;18(4):549-559. doi: 10.1158/1541-7786.MCR-19-0956. Epub 2020 Jan 15.


    8. Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation.

      Kabata H, Flamar AL, Mahlakõiv T, Moriyama S, Rodewald HR, Ziegler SF, Artis D.

      Mucosal Immunol. 2020 Feb 17. doi: 10.1038/s41385-020-0266-x. Online ahead of print.


    9. Factors associated with improvements in subjective symptoms of obstructive sleep apnea syndrome after continuous positive airway pressure therapy.
      Otsuka K, Fukunaga K, WakakoYamasawa, Haraguchi M, Tani T, Shirahama R, Betsuyaku T.
      Sleep Breath. 2020 Jun;24(2):491-498. doi: 10.1007/s11325-019-01877-5. Epub 2019 Jul 6.

    10. Acute Onset Olfactory/Taste Disorders are Associated with a High ViralBurden in Mild or Asymptomatic SARS-CoV-2.

      Nakagawara K, Masaki K, Uwamino Y, Kabata H, Uchida S, Uno S, Asakura T, Funakoshi T, Kanzaki S, Ishii M, Hasegawa N, Fukunaga K.

      Infections Int J Infect Dis. Jul 26;S1201-9712(20)30578-6. doi:10.1016/j.ijid.2020.07.034.


    11. Clinical characteristics of patients with not well-controlled severe asthma in Japan: Analysis of the Keio Severe Asthma Research Program in Japanese population (KEIO-SARP) registry.

      Tanosaki T, Kabata H, Matsusaka M, Miyata J, Masaki K, Mochimaru T, Okuzumi S, Kuwae M, Watanabe R, Suzuki Y, Sayama K, Izuhara K, Asano K, Fukunaga K.

      Allergol Int. 2020:S1323-8930(20)30091-5. doi: 10.1016/j.alit.2020.06.002. Online ahead of print.


    12. Risk factors for poor adherence to inhaled corticosteroid therapy in patients with moderate to severe asthma.

      Masaki K, Miyata J, Kamatani T, Takae T, Mochimaru T, Kabata H, Suzuki Y, Asano K, Betsuyaku T, Fukunaga K.

      Asian Pac J Allergy Immunol. 2020 Jun 21. doi: 10.12932/AP-311219-0731.


    13. Placental transmogrification of the lung masquerading as difficult-to-treat pneumonia.

      Horiuchi K, Asakura T, Sakaguchi S, Saito F, Yamamoto J.

      QJM. 2020 Mar 1;113(3):213-214. doi: 10.1093/qjmed/hcz153.


    14. Intracellular levels of reactive oxygen species correlate with ABT-263 sensitivity in non-small-cell lung cancer cells.

      Ohgino K, Terai H, Yasuda H, Nukaga S, Hamamoto J, Tani T, Kuroda A, Arai D, Ishioka K, Masuzawa K, Ikemura S, Kawada I, Naoki K, Fukunaga K, Soejima K.

      Cancer Sci. 2020 Jul 20. doi: 10.1111/cas.14569. Online ahead of print.


    15. A case of non-severe COVID-19 complicated by pulmonary embolism.

      Akiyama Y, Horiuchi K, Kondo Y, Kabata H, Ishii M, Fukunaga K.

      Respirol Case Rep. 2020 Jul 15;8(7):e00622. doi: 10.1002/rcr2.622. eCollection 2020 Oct.


    16. Key prognostic factors for EGFR-mutated non-adenocarcinoma lung cancer patients in the Japanese Joint Committee of Lung Cancer Registry Database.

      Kobayashi K, Soejima K, Fukunaga K, Shintani Y, Sekine I, Shukuya T, Takayama K, Inoue A, Okamoto I, Kiura K, Takahashi K, Yamamoto N, Takiguchi Y, Miyaoka E, Okumura M, Yoshino I; Group on behalf of the Japanese Joint Committee of Lung Cancer Registry.

      Lung Cancer. 2020 Aug;146:236-243. doi: 10.1016/j.lungcan.2020.06.015. Epub 2020 Jun 18.


    17. ADAM17 protects against elastase-induced emphysema by suppressing CD62L + leukocyte infiltration in mice.

      Suzuki S, Ishii M, Asakura T, Namkoong H, Okamori S, Yagi K, Kamata H, Kusumoto T, Kagawa S, Hegab AE, Yoda M, Horiuchi K, Hasegawa N, Betsuyaku T.

      Am J Physiol Lung Cell Mol Physiol. 2020 Jun 1;318(6):L1172-L1182. doi: 10.1152/ajplung.00214.2019. Epub 2020 Mar 4.


    18. Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports.

      Okamori S, Lee H, Kondo Y, Akiyama Y, Kabata H, Kaneko Y, Ishii M, Hasegawa N, Fukunaga K.

      Medicine (Baltimore). 2020 Aug 28;99(35):e21804. doi: 10.1097/MD.0000000000021804.


    19. Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: a multicenter retrospective study.

      Ishii M, Terai H, Kabata H, Masaki K, Chubachi S, Tateno H, Nakamura M, Nishio K, Koh H, Watanabe R, Ueda S, Terashima T, Suzuki Y, Yagi K, Miyao N, Minematsu N, Inoue T, Nakachi I, Namkoong H, Okamori S, Ikemura S, Kamata H, Yasuda H, Kawada I, Hasegawa N, Fukunaga K; Keio COVID-19 Research Consortium (K-CORC) and the Keio Donner Project Team.

      J Infect. 2020 Sep 10:S0163-4453(20)30590-9. doi: 10.1016/j.jinf.2020.08.052. Online ahead of print.


    20. Analysis of clinical outcomes in elderly patients with impaired swallowing function.

      Sunata K, Terai H, Seki H, Mitsuhashi M, Kagoshima Y, Nakayama S, Wakabayashi K, Muraoka K, Suzuki Y, Suzuki Y.

      PLoS One. 2020 Sep 18;15(9):e0239440. doi: 10.1371/journal.pone.0239440. eCollection 2020.


    21. Blood eosinophil and neutrophil counts differentially identify frequent exacerbation in patients with COPD with physician-diagnosed asthma and COPD.

      Mochimaru T, Chubachi S, Irie H, Sakurai K, Okuzumi S, Sunata K, Masaki K, Miyata J, Nakamura H, Asano K, Fukunaga K.

      Allergol Int. 2020 Oct 18:S1323-8930(20)30129-5. doi: 10.1016/j.alit.2020.09.004. Online ahead of print.


    22. Functional dissection of the KRAS G12C mutation by comparison among multiple oncogenic driver mutations in a lung cancer cell line model.

      Kobayashi K, Terai H, Yasuda H, Hamamoto J, Hayashi Y, Takeuchi O, Mitsuishi Y, Masuzawa K, Manabe T, Ikemura S, Kawada I, Suzuki Y, Soejima K, Fukunaga K.

      Biochem Biophys Res Commun. 2020 Dec 7;534:1-7. doi: 10.1016/j.bbrc.2020.11.110. Online ahead of print.


    23. Optimizing the in vitro colony-forming assay for more efficient delineation of the interaction between lung epithelial stem cells and their niche.

      Ozaki M, Kagawa S, Ishii M, Hegab AE.

      J Stem Cells Regen Med. 2020 Dec 11;16(2):50-62. doi: 10.46582/jsrm.1602009. eCollection 2020.


    24. The Effectiveness of Nasal Airway Stent Therapy for the Treatment of Mild-to-Moderate Obstructive Sleep Apnea Syndrome.

      Ohtsuka K, Baba R, Yamasawa W, Shirahama R, Hattori Y, Senoura H, Betsuyaku T, Fukunaga K.

      Respiration. 2020 Dec 28:1-8. doi: 10.1159/000512319. Online ahead of print.



トピックス

  • 同門会(要パスワード)
  • サタデーレクチャー(要パスワード)
  • 寄附講座
  • 患者様へ 臨床研究について

page top


Copyright(c) 2024 Keio University Hospital. All rights reserved.